Literature DB >> 31431030

Evaluation and management of incidental gallbladder cancer.

Mohammad Y Zaidi1, Ghassan K Abou-Alfa2, Cecilia G Ethun1, Shailesh V Shrikhande3, Mahesh Goel3, Bruno Nervi4, John Primrose5, Juan W Valle6, Shishir K Maithel7.   

Abstract

Given the ubiquity of laparoscopic cholecystectomy in the modern era, the incidence of incidentally diagnosed gallbladder cancers (GBCs) is rising. This unique clinical scenario poses specific challenges regarding the role of staging, re-resection, and adjuvant treatment for patients with this disease. This review will address these controversies with the latest published data.

Entities:  

Keywords:  Incidental gallbladder cancer (incidental GBC); chemotherapy; re-resection

Mesh：

Year:  2019        PMID： 31431030      PMCID： PMC8289444          DOI： 10.21037/cco.2019.07.01

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN： 2304-3865


  44 in total

1.  Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries.

Authors:  Jean M Butte; Kenichi Matsuo; Mithat Gönen; Michael I D'Angelica; Enrique Waugh; Peter J Allen; Yuman Fong; Ronald P DeMatteo; Leslie Blumgart; Itaru Endo; Hernán De La Fuente; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2010-11-12       Impact factor: 6.113

2.  An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center.

Authors:  Elijah Dixon; Charles M Vollmer; Ajay Sahajpal; Mark Cattral; David Grant; Christopher Doig; Al Hemming; Bryce Taylor; Bernard Langer; Paul Greig; Steven Gallinger
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

3.  Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.

Authors:  John N Primrose; Richard P Fox; Daniel H Palmer; Hassan Z Malik; Raj Prasad; Darius Mirza; Alan Anthony; Pippa Corrie; Stephen Falk; Meg Finch-Jones; Harpreet Wasan; Paul Ross; Lucy Wall; Jonathan Wadsley; Jeff T R Evans; Deborah Stocken; Raaj Praseedom; Yuk Ting Ma; Brian Davidson; John P Neoptolemos; Tim Iveson; James Raftery; Shihua Zhu; David Cunningham; O James Garden; Clive Stubbs; Juan W Valle; John Bridgewater
Journal:  Lancet Oncol       Date:  2019-03-25       Impact factor: 41.316

4.  Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment.

Authors:  Hiromichi Ito; Kaori Ito; Michael D'Angelica; Mithat Gonen; David Klimstra; Peter Allen; Ronald P DeMatteo; Yuman Fong; Leslie H Blumgart; William R Jarnagin
Journal:  Ann Surg       Date:  2011-08       Impact factor: 12.969

Review 5.  Carcinoma of the gallbladder.

Authors:  Sanjeev Misra; Arun Chaturvedi; Naresh C Misra; Indra D Sharma
Journal:  Lancet Oncol       Date:  2003-03       Impact factor: 41.316

6.  The role of laparoscopic staging in patients with incidental gallbladder cancer.

Authors:  Jean M Butte; Mithat Gönen; Peter J Allen; Michael I D'Angelica; T Peter Kingham; Yuman Fong; Ronald P Dematteo; Leslie Blumgart; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2011-06-07       Impact factor: 3.647

7.  Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma.

Authors:  S Kondo; Y Nimura; N Hayakawa; J Kamiya; M Nagino; K Uesaka
Journal:  Br J Surg       Date:  2000-04       Impact factor: 6.939

8.  Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study.

Authors:  Julien Edeline; Meher Benabdelghani; Aurélie Bertaut; Jérôme Watelet; Pascal Hammel; Jean-Paul Joly; Karim Boudjema; Laetitia Fartoux; Karine Bouhier-Leporrier; Jean-Louis Jouve; Roger Faroux; Véronique Guerin-Meyer; Jean-Emmanuel Kurtz; Eric Assénat; Jean-François Seitz; Isabelle Baumgaertner; David Tougeron; Christelle de la Fouchardière; Catherine Lombard-Bohas; Eveline Boucher; Trevor Stanbury; Christophe Louvet; David Malka; Jean-Marc Phelip
Journal:  J Clin Oncol       Date:  2019-02-01       Impact factor: 44.544

9.  Patterns of failure and determinants of outcomes following radical re-resection for incidental gallbladder cancer.

Authors:  Savio George Barreto; Satish Pawar; Sanket Shah; Sanjay Talole; Mahesh Goel; Shailesh V Shrikhande
Journal:  World J Surg       Date:  2014-02       Impact factor: 3.352

10.  Is port-site resection necessary in the surgical management of gallbladder cancer?

Authors:  D Fuks; J-M Regimbeau; P Pessaux; P Bachellier; A Raventos; G Mantion; J-F Gigot; L Chiche; G Pascal; D Azoulay; A Laurent; C Letoublon; E Boleslawski; M Rivoire; J-Y Mabrut; M Adham; Y-P Le Treut; J-R Delpero; F Navarro; A Ayav; K Boudjema; G Nuzzo; M Scotte; O Farges
Journal:  J Visc Surg       Date:  2013-05-09       Impact factor: 2.043
View more
  2 in total

1.  Comment on: development and external validation of a model to predict overall survival in patients with resected gallbladder cancer.

Authors:  Sakti Chakrabarti; Amit Mahipal
Journal:  Hepatobiliary Surg Nutr       Date:  2022-02       Impact factor: 7.293

2.  Incidental gallbladder cancer: a retrospective clinical study of 40 cases.

Authors:  Merih Altiok; Hanife Gülnihal Özdemir; Feyzi Kurt; Mehmet Onur Gul; Serdar Gumus
Journal:  Ann Surg Treat Res       Date:  2022-04-05       Impact factor: 1.766
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.